116 related articles for article (PubMed ID: 31964530)
1. Ubiquitin-specific protease 14 promotes prostate cancer progression through deubiquitinating the transcriptional factor ATF2.
Geng L; Chen X; Zhang M; Luo Z
Biochem Biophys Res Commun; 2020 Mar; 524(1):16-21. PubMed ID: 31964530
[TBL] [Abstract][Full Text] [Related]
2. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
[TBL] [Abstract][Full Text] [Related]
3. Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2.
Xu X; Xia J; Zhao S; Wang Q; Ge G; Xu F; Liu X; Zhang W; Yang Y
FASEB J; 2021 Sep; 35(9):e21870. PubMed ID: 34436790
[TBL] [Abstract][Full Text] [Related]
4. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.
Deng X; Liu H; Huang J; Cheng L; Keller ET; Parsons SJ; Hu CD
Cancer Res; 2008 Dec; 68(23):9663-70. PubMed ID: 19047143
[TBL] [Abstract][Full Text] [Related]
6. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
7. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
9. Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.
Hsu CC; Hu CD
J Biol Chem; 2012 Mar; 287(11):8621-32. PubMed ID: 22275354
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.
Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
FEBS J; 2016 Mar; 283(5):929-46. PubMed ID: 26758085
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer.
Su Y; Zeng K; Liu S; Wu Y; Wang C; Wang S; Lin L; Zou R; Sun G; Luan R; Zhou B; Bai Y; Niu J; Zhang Y; Zhao Y
J Biol Chem; 2023 Jan; 299(1):102734. PubMed ID: 36423684
[TBL] [Abstract][Full Text] [Related]
13. p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma.
Song WJ; Dong Y; Luo C; Chen YY
Pathol Res Pract; 2017 Oct; 213(10):1282-1288. PubMed ID: 28916425
[TBL] [Abstract][Full Text] [Related]
14. Identification of ATF2 as a transcriptional regulator of renin gene.
Desch M; Hackmayer G; Todorov VT
Biol Chem; 2012 Jan; 393(1-2):93-100. PubMed ID: 22628303
[TBL] [Abstract][Full Text] [Related]
15. USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro.
Han KH; Kwak M; Lee TH; Park MS; Jeong IH; Kim MJ; Jin JO; Lee PC
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653087
[TBL] [Abstract][Full Text] [Related]
16. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
[TBL] [Abstract][Full Text] [Related]
17. NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathway.
Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
Clin Transl Oncol; 2023 Jan; 25(1):243-255. PubMed ID: 36136271
[TBL] [Abstract][Full Text] [Related]
18. Expression of the transcriptional repressor ATF3 in gonadotrophs is regulated by Egr-1, CREB, and ATF2 after gonadotropin-releasing hormone receptor stimulation.
Mayer SI; Dexheimer V; Nishida E; Kitajima S; Thiel G
Endocrinology; 2008 Dec; 149(12):6311-25. PubMed ID: 18719024
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential melastatin-3 (TRPM3)-induced activation of AP-1 requires Ca2+ ions and the transcription factors c-Jun, ATF2, and ternary complex factor.
Lesch A; Hui X; Lipp P; Thiel G
Mol Pharmacol; 2015 Apr; 87(4):617-28. PubMed ID: 25576487
[TBL] [Abstract][Full Text] [Related]
20. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]